Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This clinical study is a Phase I, open-label, single-center study designed to evaluate the pharmacokinetics profile of a single oral dose of GLPG3067 in adult male subjects with cystic fibrosis in fed state.
Epistemonikos ID: ae058d74abe3f0eb36df88d8dbf0d29e46c7bf88
First added on: May 21, 2024